Inventor · disambiguated record
Euh Lim Oh
Also filed as: OH EUH LIM
11 granted patents·15 pending applications·48 citations·filing 2012–2023
87Inventor score
Top patents by PatentIndex Score
26 records- 0198US10370426B2Triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2018·Granted Aug 6, 2019·21 cites·16 claims
- 0293US10400020B2Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2018·Granted Sep 3, 2019·10 cites·24 claims
- 0390US11332508B2Triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2019·Granted May 17, 2022·2 cites·34 claims
- 0490US9394546B2Recombinant yeast transformant and process for preparing immunoglobulin Fc fragment employing the sameHANMI PHARM IND CO LTD·Filed 2014·Granted Jul 19, 2016·8 cites·13 claims
- 0589US11746137B2Immunostimulating IL-2 analogsHANMI PHARM IND CO LTD·Filed 2021·Granted Sep 5, 2023·2 cites·1 claims
- 0686US10981967B2Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2019·Granted Apr 20, 2021·3 cites·41 claims
- 0780US2022213164A1Triple glucagon/glp-1/gip receptor agonistHANMI PHARM IND CO LTD·Filed 2022·Application pending·0 cites
- 0875US10253082B2Long-acting insulin and use thereofHANMI PHARM IND CO LTD·Filed 2015·Granted Apr 9, 2019·2 cites·18 claims
- 0975US2021188937A1Long-acting conjugate of triple glucagon/glp-1/gip receptor agonistHANMI PHARM IND CO LTD·Filed 2021·Application pending·0 cites
- 1073US12415842B2Immunostimulating IL-2 analogsHANMI PHARMACEUTICAL CO LTD·Filed 2023·Granted Sep 16, 2025·0 cites·5 claims
- 1164US10647753B2Insulin analogs and use thereofHANMI PHARM IND CO LTD·Filed 2018·Granted May 12, 2020·0 cites·6 claims
- 1262US2025099574A1Coronavirus vaccineHANMI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1362US2025114463A1Liver-targeted drug and use thereofHANMI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1459US2023382974A1Novel triple agonist having activities on all of glucagon, glp-1, and gip receptors and use thereofHANMI PHARM IND CO LTD·Filed 2021·Application pending·0 cites
- 1558US2023381333A1Pharmaceutical composition comprising glucagon/glp-1/gip triple agonist or long-acting conjugate thereof for preventing or treating vasculitisHANMI PHARM IND CO LTD·Filed 2021·Application pending·0 cites
- 1657US2023310630A1Therapeutic use of combination comprising triple agonistic long-acting conjugate or triple agonistHANMI PHARM IND CO LTD·Filed 2021·Application pending·0 cites
- 1757US2024301433A1Non-natural 5'-untranslated region and 3'-untranslated region and use thereofHANMI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1857US2023381281A1Pharmaceutical composition comprising glucagon/glp-1/gip triple agonist or long-acting conjugate thereof for preventing or treating lupus-related diseasesHANMI PHARM IND CO LTD·Filed 2021·Application pending·0 cites
- 1955US2024024426A1Hypotensive pharmaceutical composition comprising triple activator having activity for all of glucagon, glp-1, and gip receptorsHANMI PHARM IND CO LTD·Filed 2021·Application pending·0 cites
- 2053US2023390362A1Use of trigonal agonist having activities to all of glucagon, glp-1, and gip receptors in treatment of sequelae following respiratory infectious diseasesHANMI PHARM IND CO LTD·Filed 2021·Application pending·0 cites
- 2149US2023118307A1Therapeutic use of long-acting conjugate of triple agonist having activities to all of glucagon/glp-1/gip receptors for lung diseaseHANMI PHARM IND CO LTD·Filed 2020·Application pending·0 cites
- 2248US10017557B2Insulin analogs and use thereofHANMI PHARM IND CO LTD·Filed 2016·Granted Jul 10, 2018·0 cites·15 claims
- 2348US2022025007A1Novel immunosuppressive interleukin 2HANMI PHARM IND CO LTD·Filed 2019·Application pending·0 cites
- 2447US9394560B2Method of culturing E. coli cells for high densityHANMI SCIENCE CO LTD·Filed 2013·Granted Jul 19, 2016·0 cites·17 claims
- 2547US2020254108A1Long-acting single-chain insulin analog and conjugate thereofHANMI PHARM IND CO LTD·Filed 2018·Application pending·0 cites
- 2643US2014357843A1Immunoglobulin fc variantsHANMI SCIENCE CO LTD·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Euh Lim Oh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →